e-learning
resources
Munich 2006
Monday 04.09.2006
Cellular biology of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF
A. Kollintza, I. Sigala, I. Porfyridis, G. T. Stathopoulos, C. Moschos, C. Roussos, K. Ioannis (Athens, Greece)
Source:
Annual Congress 2006 - Cellular biology of asthma and COPD
Session:
Cellular biology of asthma and COPD
Session type:
Poster Discussion
Number:
3176
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kollintza, I. Sigala, I. Porfyridis, G. T. Stathopoulos, C. Moschos, C. Roussos, K. Ioannis (Athens, Greece). Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF. Eur Respir J 2006; 28: Suppl. 50, 3176
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion
Source: Annual Congress 2008 - Pleural effusion
Year: 2008
Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions
Source: Eur Respir J 2002; 19: 320-325
Year: 2002
Angiopoietin-2 levels are elevated in exudative pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
Elevated IL-18 levels in exudative pleural effusions, correlation with markers of pleural inflammation
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
The role of vascular endothelial growth factor in tuberculous and parapneumonic pleural effusions
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008
Incidence and aetiology of eosinophilic pleural effusion
Source: Eur Respir J 2009; 34: 1111-1117
Year: 2009
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003
Hyaluronic acid levels are increased in parapneumonic pleural effusions
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011
Pleural fluid interleukin-10 level in the diagnosis of tuberculous effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 581s
Year: 2002
Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021
Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006
Prognostic features of residual pleural thickening after parapneumonic pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 605s
Year: 2002
Diagnostic value of IL-8 in differentiating between exudative and transudative pleural effusion
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Prognostic features of residual pleural thickening in parapneumonic pleural effusions
Source: Eur Respir J 2003; 21: 952-955
Year: 2003
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept